CGRP Drugs Versus Devices: Which Prevents More?
If you wake with a headache, jaw soreness, or a migraine already gathering force, the CGRP drugs versus devices question is not simply a medication choice. It is a prevention question: are you only blocking a pain signal after the migraine system is activated, or are you reducing a source of trigeminal input that may be helping activate it in the first place?
For many people, CGRP-targeting medications have changed the migraine landscape. They can reduce migraine days and disability without the broad side-effect burden associated with some older preventive drugs. But they are not the only evidence-based prevention path, and they do not answer every mechanism that can feed migraine sensitization - especially repeated nighttime jaw clenching and muscular overactivity.
What CGRP Drugs Are Designed to Do
Calcitonin gene-related peptide, or CGRP, is a neuropeptide involved in migraine biology. During an attack, CGRP-related signaling helps amplify pain transmission in the trigeminal system, the major sensory pathway implicated in migraine. CGRP medications were developed to interrupt that process.
Preventive CGRP therapies generally fall into two categories. Monoclonal antibodies are typically injections or infusions given monthly or quarterly. Small-molecule CGRP antagonists, often called gepants, are oral medications that may be used for prevention, acute treatment, or both depending on the specific drug and prescription.
Their appeal is clear. They are migraine-specific, relatively convenient for many patients, and can be highly meaningful for people with frequent attacks. Yet their central role is to reduce or block a chemical signaling pathway. That is different from identifying and reducing the physical or neurologic inputs that may repeatedly provoke the pathway.
Think of CGRP blockade as reducing the alarm signal. For some patients, that is exactly what is needed. For others, the alarm may still be getting triggered night after night by a source of trigeminal nociception that has not been addressed.
CGRP Drugs Versus Devices: Different Prevention Models
The most useful comparison is not “medication good, device good.” It is whether each option fits the pattern of your migraine.
CGRP drugs work systemically. They circulate through the body or act through systemic drug exposure to alter CGRP-related signaling. This can make them valuable when migraine biology is widespread, attacks occur throughout the day, or a patient has no obvious mechanical contributor. Their limitations may include cost, insurance hurdles, injections or ongoing prescriptions, and side effects that vary by product and person. Constipation, nausea, injection-site reactions, and fatigue can occur, though individual risk depends on the medication.
Neuromodulation devices take a different route. Some use electrical or magnetic stimulation to influence nerves involved in migraine. Others, including an anterior bite device designed for nighttime use, aim to reduce excessive trigeminal input associated with clenching and muscle hyperactivity during sleep. Rather than changing a chemical messenger throughout the body, the goal is to change the incoming signal before it can contribute to sensitization.
That distinction matters for the patient who says, “My migraines start in the morning,” “I wake up with tight temples,” or “My jaw feels worked over before the day even begins.” Those clues do not prove clenching causes every migraine. They do, however, justify examining the trigeminal load created during sleep.
Why the Jaw Can Matter in Migraine Prevention
The jaw is not separate from migraine physiology. The muscles of mastication, teeth, temporomandibular structures, and facial tissues are richly connected to the trigeminal nerve. Persistent jaw clenching can generate nociceptive input - danger signaling from stressed muscles and tissues - that reaches the same broad system involved in migraine pain processing.
Over time, repeated input can contribute to peripheral and central sensitization. In plain language, the nervous system becomes easier to set off. A normal trigger, such as disrupted sleep, stress, hormonal change, light exposure, or a skipped meal, may then require less force to tip the system into a full migraine.
This is why a morning pattern deserves more than a generic recommendation to “wear a nightguard.” Conventional full-coverage dental splints are often intended to protect teeth. Tooth protection can be important, but it is not the same clinical objective as reducing pathologic clenching. Some designs permit or even encourage heavy posterior tooth contact, which may allow strong jaw-muscle recruitment to continue.
An anterior-only device works from a different mechanical principle. By limiting contact to a single anterior point, it can reduce leverage available to the powerful posterior teeth and jaw-closing muscles. The intended result is less sustained clenching force and less trigeminal nociceptive input during sleep. That is a prevention strategy directed upstream of the migraine attack.
When a Device May Be the More Logical First Step
A non-drug device is particularly compelling when the migraine pattern includes waking headaches, morning migraine, jaw fatigue, tooth wear, temple tenderness, partner-reported grinding, or symptoms that have persisted despite standard nightguards. It may also appeal to people who want to reduce medication exposure, cannot tolerate preventive drugs, are concerned about ongoing prescriptions, or want an approach that can be used alongside medical care.
The FDA-cleared NTI MigraineGuard is designed around this specific mechanism: reducing nocturnal trigeminal stimulation associated with clenching through controlled anterior contact. It is not a standard boil-and-bite guard, and it should not be evaluated as though all mouthpieces function the same way.
That said, a device is not a universal substitute for medical treatment. Migraine is a neurologic disease with multiple drivers. If your attacks are associated with aura, menstrual changes, vestibular symptoms, severe nausea, all-day triggers, or a high monthly migraine burden, CGRP therapy may be appropriate, either alone or in combination with a device-based strategy. Prevention is not a loyalty test between categories. It is a mechanism-matching exercise.
The Trade-Offs Patients Should Consider
CGRP medications can be powerful because they target a well-established migraine pathway. They may be a strong choice when attacks are frequent and disabling despite behavioral changes, when there is no clear sleep or jaw component, or when a clinician believes pharmacologic prevention is necessary. Their efficacy must be weighed against access, cost, side effects, and the commitment to continued dosing.
Devices avoid systemic drug exposure and can be appealing for nightly prevention, but they require consistent use and proper fit. An oral device may not be suitable for every dental or jaw condition. People with significant tooth instability, certain bite problems, active dental pain, or complex temporomandibular disorders should seek appropriate professional guidance before choosing an oral appliance.
There is also a timing difference. A preventive CGRP medication may take weeks or months to show its full effect. A device that reduces nighttime clenching addresses the exposure each night it is worn, although migraine improvement can still take time as a sensitized nervous system settles. Neither option should be judged after only a few difficult days.
A Better Question Than “Which One Wins?”
The better question is: what is continuously feeding your migraine threshold?
If CGRP-related signaling is the main actionable target, medication may offer substantial relief. If sleep-related jaw activity is repeatedly loading the trigeminal system, addressing that input may be the missing prevention layer. And if both are true, combining clinician-directed drug therapy with a non-drug strategy may be more rational than escalating either one in isolation.
Do not let a normal dental nightguard be mistaken for migraine prevention, and do not assume that a migraine prescription automatically addresses every trigger reaching your nervous system. Track when attacks begin, how your jaw feels on waking, and whether mornings are consistently worse. Those details can turn a frustrating treatment history into a more precise prevention plan.